Global B-cell non hodgkin lymphoma drugs market 2018-2022
About B-Cell Non-Hodgkin Lymphoma Drugs
B-cell non-Hodgkin lymphoma (NHL) is a type of cancer that forms in B-cells. It may be either indolent (slow-growing) or aggressive (fast-growing). Most B-cell lymphomas are non-Hodgkin lymphomas. There are various types of B-cell NHL including Burkitt lymphoma, chronic lymphocytic leukemia (CLL), follicular lymphoma, and mantle cell lymphoma.
Technavio’s analysts forecast the Global B-Cell Non-Hodgkin Lymphoma Drugs Market to grow at a CAGR of 7.52% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the B-cell non-Hodgkin lymphoma drugs market. To calculate the market size, the report considers the revenue generated from the retail sales of B-cell non-Hodgkin lymphoma drugs across the globe.
The market is divided into the following segments based on geography:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook